Peter Mueller

2009

In 2009, Peter Mueller earned a total compensation of $9.3M as EVP, Global Research and Development, & Chief Scientific Officer at Vertex Pharmaceuticals, a 211% increase compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$495,000
Option Awards$7,803,839
Salary$538,029
Stock Awards$405,297
Other$12,421
Total$9,254,586

Mueller received $7.8M in option awards, accounting for 84% of the total pay in 2009.

Mueller also received $495K in non-equity incentive plan, $538K in salary, $405.3K in stock awards and $12.4K in other compensation.

Rankings

In 2009, Peter Mueller's compensation ranked 255th out of 9,885 executives tracked by ExecPay. In other words, Mueller earned more than 97.4% of executives.

ClassificationRankingPercentile
All
255
out of 9,885
97th
Division
Manufacturing
89
out of 3,690
98th
Major group
Chemicals And Allied Products
24
out of 866
97th
Industry group
Drugs
21
out of 638
97th
Industry
Pharmaceutical Preparations
19
out of 446
96th
Source: SEC filing on April 10, 2012.

Mueller's colleagues

We found six more compensation records of executives who worked with Peter Mueller at Vertex Pharmaceuticals in 2009.

2009

Matthew Emmens

Vertex Pharmaceuticals

Chief Executive Officer

2009

Nancy Wysenski

Vertex Pharmaceuticals

EVP & Chief Commercial Officer

2009

Joshua Boger

Vertex Pharmaceuticals

Chief Executive Officer

2009

Ian Smith

Vertex Pharmaceuticals

Chief Financial Officer

2009

Amit Sachdev

Vertex Pharmaceuticals

Senior Vice President, Corporate Affairs and Public Policy, and Commercial Business Lead, Canada

2009

Kenneth Boger

Vertex Pharmaceuticals

Chief Legal Officer

In-depth

You may also like